Article
Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.
Antiviral therapy - 1 Apr 2004
Bartholomeusz Angeline, Tehan Benjamin G, Chalmers David K
Abstract excerpt
The antiviral treatment of chronic hepatitis B is limited by the selection of antiviral resistance mutations. Primary resistance to lamivudine occurs at rtM2041/V in the C Domain of the polymerase. Recently, resistance to adefovir has also been described in the D Domain at rtN236T. The treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
